Press release
Market Trend Insights: The Impact of Recent Advances on the Peptide Therapeutics Market
Peptide Therapeutics
Projected Market Size and Expansion of the Peptide Therapeutics Market
The peptide therapeutics market is forecasted to grow rapidly, reaching a valuation of $74.98 billion by 2029. This impressive growth corresponds to a compound annual growth rate (CAGR) of 11.1%. Several factors are propelling this surge, including the heightened demand for personalized medical treatments, broader applications in immunotherapy, improvements in peptide delivery technologies, discovery of new peptide targets for infectious diseases, and an increased focus on rare diseases. Additionally, the market is shaped by trends such as technological progress in peptide synthesis, growing investment activities, prioritization of drug safety, expansion into emerging markets, and integration of artificial intelligence (AI) in various stages of development.
Download a free sample of the peptide therapeutics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp
Key Factors Behind the Rising Demand for Peptide Therapeutics
One major driver fueling the market is the growing interest in personalized medicine, which tailors treatments to individual patient profiles, enhancing effectiveness and reducing side effects. Peptides offer unique advantages that align well with this approach, making them valuable tools in precision healthcare.
Another important factor is the expanding use of peptide-based therapies in immunotherapy, which is becoming a cornerstone of modern treatment strategies for cancer and autoimmune diseases. Advances in delivery systems also contribute by improving the stability and bioavailability of peptides, thereby increasing their therapeutic potential.
Leading Companies Making an Impact in the Peptide Therapeutics Market
The peptide therapeutics market features several prominent players, including Pfizer Inc., Johnson & Johnson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., and Merck & Co Inc.
View the full peptide therapeutics market report:
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
Significant Acquisition Highlighting Market Consolidation
In July 2024, AstraZeneca plc, a pharmaceutical and biotechnology leader based in England, acquired France-based Amolyt Pharma for $1.05 billion. Amolyt Pharma specializes in clinical-stage development of therapeutic peptides targeting rare endocrine and metabolic disorders. This acquisition supports AstraZeneca's strategic goals to bolster its rare disease portfolio and expand its therapeutic reach in critical areas of unmet medical need.
Innovations Fueling the Peptide Therapeutics Market
Companies in this field are focusing on introducing advanced technologies such as cell culture processes to enhance their competitive positioning. Cell culture involves growing cells in controlled environments outside the body, which is essential for developing biological drugs.
For example, Evonik Industries AG, a German specialty chemicals company, launched cQrex KC in June 2023. This next-generation peptide is designed to improve cell culture processes used in biopharmaceutical manufacturing. It optimizes cystine supply, boosting productivity in vaccine production, viral vectors, and cell therapies, thereby supporting innovation in peptide-based drug development.
Detailed Segmentation of the Peptide Therapeutics Market
The market is organized into several key segments:
1) By Type: Generic and Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, and Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous System disorders, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, and Other Applications
Further distinctions within these categories include:
- Generic Peptides: Generic Peptide Drugs and Biosimilars
- Branded Peptides: Innovative Peptide Drugs and Patent-Protected Peptides
This structured segmentation allows for a comprehensive understanding of the market's composition and potential growth avenues.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Market Trend Insights: The Impact of Recent Advances on the Peptide Therapeutics Market here
News-ID: 4318914 • Views: …
More Releases from The Business Research Company
Future Perspectives: Key Trends Shaping the Pulmonary Arterial Hypertension Mark …
The pulmonary arterial hypertension (PAH) market is on track for significant expansion in the coming years, driven by advancements in treatment options and growing healthcare initiatives. As new therapies emerge and diagnostic methods improve, the PAH landscape is evolving rapidly, creating promising opportunities for patients and industry stakeholders alike.
Projected Growth and Market Size of the Pulmonary Arterial Hypertension Market
The pulmonary arterial hypertension market is anticipated to reach a…
Emerging Sub-Segments Transforming the PMS and Menstrual Health Supplements Mark …
The market for PMS and menstrual health supplements is on track for significant expansion over the coming years, driven by growing consumer awareness and evolving healthcare priorities. This sector is becoming increasingly important as more women seek natural and effective ways to manage menstrual and hormonal health. Let's explore the current market outlook, major players, emerging trends, and segment details shaping this dynamic industry.
Projected Growth Trajectory of the PMS and…
Emerging Sub-Segments Transforming the Nicotine Addiction Treatment Market Lands …
The nicotine addiction treatment market is set for significant expansion as efforts to address tobacco dependency intensify worldwide. With rising awareness and evolving healthcare strategies, this sector is expected to experience substantial growth driven by a combination of regulatory support, innovation, and changing consumer preferences. Let's explore the current market size, key players, emerging trends, and the structure of this evolving industry.
Nicotine Addiction Treatment Market Size and Growth Forecast Through…
Market Trend Analysis: The Impact of Recent Advancements on the Janus Kinase (JA …
The Janus Kinase (JAK) inhibitors market is gaining significant attention due to advances in medical research and growing demand for targeted therapies. With new developments in personalized medicine and innovative treatment options, this market is set for substantial expansion over the next few years. Let's explore the market size projections, leading companies, influential trends, and key segments shaping the future of JAK inhibitors.
Projected Growth and Size of the Janus Kinase…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
